DELFI Diagnostics Receives New York State Approval for Lung Cancer Blood Test
The authorization from the New York State Department of Health makes the screening test available in all 50 states.
Read MorePosted by CLP Edit Staff | May 29, 2026 | Compliance, Lung Cancer |
The authorization from the New York State Department of Health makes the screening test available in all 50 states.
Read MorePosted by CLP Edit Staff | May 28, 2026 | Compliance, Lab Management, Molecular Diagnostics |
The settlement follows a criminal conviction and addresses more than $174 million in fraudulent Medicare claims involving multiple laboratories.
Read MorePosted by CLP Edit Staff | May 14, 2026 | Compliance, Lab Management |
Applicable laboratories are required to report information to CMS for each clinical diagnostic laboratory test that the laboratory furnishes.
Read MorePosted by CLP Edit Staff | May 14, 2026 | Cancer, Company News, Molecular Diagnostics |
Caris Life Sciences has applied to the New York State Department of Health for authorization of Caris Assure, a blood-based molecular profiling test for cancer using whole exome and transcriptome sequencing of 22,000 genes.
Read MorePosted by CLP Edit Staff | May 13, 2026 | Accreditation, Immunoassay, Immunoassay Instrumentation |
The certification verifies that the automated immunoassay provides results equivalent to the gold standard method for measuring total testosterone.
Read More